Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Isolating peripheral effects of endogenous opioids in modulating exertional breathlessness in people with moderate or severe COPD: a randomised controlled trial.

Currow DC, Hunt T, Louw S, Eckert D, Allcroft P, To THM, Greene A, Krajnik M, Mahler D, Ekström M.

ERJ Open Res. 2019 Dec 23;5(4). pii: 00153-2019. doi: 10.1183/23120541.00153-2019. eCollection 2019 Oct.

2.

A Randomized, Double-Blind, Multisite, Pilot, Placebo-Controlled Trial of Regular, Low-Dose Morphine on Outcomes of Pulmonary Rehabilitation in COPD.

Kochovska S, Fazekas B, Hensley M, Wheatley J, Allcroft P, Currow DC.

J Pain Symptom Manage. 2019 Nov;58(5):e7-e9. doi: 10.1016/j.jpainsymman.2019.07.026. Epub 2019 Aug 9. No abstract available.

PMID:
31404644
3.

Stigma and the in(visible) perspectives and expectations of home oxygen therapy among people with chronic breathlessness syndrome: A qualitative study.

Breaden K, Collier A, Litster C, Allcroft P, Currow DC, Phillips JL.

Palliat Med. 2019 Jan;33(1):82-90. doi: 10.1177/0269216318805621. Epub 2018 Oct 9. No abstract available.

PMID:
30296930
4.

The need to research refractory breathlessness.

Currow DC, Abernethy AP, Allcroft P, Banzett RB, Bausewein C, Booth S, Carrieri-Kohlman V, Davidson P, Disler R, Donesky D, Dudgeon D, Ekstrom M, Farquhar M, Higginson I, Janssen D, Jensen D, Jolley C, Krajnik M, Laveneziana P, McDonald C, Maddocks M, Morelot-Panzini C, Moxham J, Mularski RA, Noble S, O'Donnell D, Parshall MB, Pattinson K, Phillips J, Ross J, Schwartzstein RM, Similowski T, Simon ST, Smith T, Wells A, Yates P, Yorke J, Johnson MJ.

Eur Respir J. 2016 Jan;47(1):342-3. doi: 10.1183/13993003.00653-2015. No abstract available.

5.

Academic detailing of general practitioners by a respiratory physician for diagnosis and management of refractory breathlessness: a randomised pilot study.

Collier A, Rowett D, Allcroft P, Greene A, Currow DC.

BMC Health Serv Res. 2015 May 9;15:193. doi: 10.1186/s12913-015-0861-9.

6.

Breathlessness in motor neurone disease: a review of the current strategies and gaps in the evidence.

Allcroft P.

Curr Opin Support Palliat Care. 2014 Sep;8(3):213-7. doi: 10.1097/SPC.0000000000000077. Review.

PMID:
25090287
7.

The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.

Allcroft P, Margitanovic V, Greene A, Agar MR, Clark K, Abernethy AP, Currow DC.

J Palliat Med. 2013 Jul;16(7):741-4. doi: 10.1089/jpm.2012.0505. Epub 2013 Apr 18.

PMID:
23597092
8.

Chronic refractory dyspnoea--evidence based management.

Wiseman R, Rowett D, Allcroft P, Abernethy A, Currow DC.

Aust Fam Physician. 2013 Mar;42(3):137-40. Review.

9.

Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study.

Currow DC, McDonald C, Oaten S, Kenny B, Allcroft P, Frith P, Briffa M, Johnson MJ, Abernethy AP.

J Pain Symptom Manage. 2011 Sep;42(3):388-99. doi: 10.1016/j.jpainsymman.2010.11.021. Epub 2011 Mar 31.

10.

Digoxin-itraconazole interaction: possible mechanisms.

Alderman CP, Allcroft PD.

Ann Pharmacother. 1997 Apr;31(4):438-40.

PMID:
9101006

Supplemental Content

Loading ...
Support Center